Delivery Order SPE2DB24D1205-SPE2DB25FDAAP
Award Date 9/2/25
Potential Completion Date 9/3/25
Potential Value $41K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $35,031.63 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. ENBREL is a biologic immunosuppressant medication used to treat autoimmune conditions...
- The Defense Logistics Agency awarded a $67,548.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors. The contract, which was competitively awarded with no set-aside designation, was executed on August 13, 2025, with an ultimate completion date of August 14, 2025. Performance will be conducted at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $10,388.67 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injector pens. This competitive, firm fixed-price delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Enbrel is a biologic immunosuppressant medication used to treat rheumatoid arthritis and other autoimmune...
- The Defense Logistics Agency awarded a delivery order valued at $82,107.06 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors. The contract, which is not set-aside, was competitively awarded on August 28, 2025, with an ultimate completion date of August 29, 2025. This firm fixed-price delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. ENBREL is a biologic immunosuppressant medication used to treat inflammatory...
- The Defense Logistics Agency awarded a delivery order valued at $11,160.01 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. ENBREL is a biologic immunosuppressant commonly used to treat rheumatoid arthritis, psoriasis, and other autoimmune...
- The Defense Logistics Agency awarded a delivery order valued at $61,490.24 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. ENBREL is a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions and is commonly stocked within...
- The Defense Logistics Agency awarded a delivery order valued at $11,509.84 to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors, with performance completion targeted for August 29, 2025. This competitive award (no set-aside designation) was issued on August 28, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. ENBREL is a TNF-inhibitor biologic medication commonly used to treat rheumatoid arthritis, psoriasis, and other inflammatory...
- The Defense Logistics Agency awarded a $15,905.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with an ultimate completion date of August 15, 2025. This non-set-aside competitive award was issued on August 14, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Enbrel is a biologic immunosuppressant medication used to treat autoimmune conditions, and the SureClick delivery...
- The Defense Logistics Agency awarded a delivery order valued at $12,535.30 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors, with an ultimate completion date of August 5, 2025. This firm fixed-price, non-set-aside contract was awarded on August 4, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Enbrel is a biologic immunosuppressant used to treat autoimmune conditions including rheumatoid arthritis, and the...
- The Defense Logistics Agency awarded a delivery order valued at $38,403.45 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of July 29, 2025. This competitive, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. ENBREL is a biologic immunosuppressant used to treat rheumatoid arthritis, psoriasis, and other...